Macrogenics (MGNX) Misses Q1 EPS by 22c

Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($1.08), $0.22 worse than the analyst estimate of ($0.86). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $21.44 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Home Depot (HD) Tops Q2 EPS by 19c, reaffirms guidance
• BioMarin to acquire Alesta Therapeutics for $275M upfront